AVESTA KHURSAND: Open Payments
NPI 1629445176 · HUNTINGTON STATION, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,417 in 14 payments from 8 companies in 2025. Trend: 2023 $715 · 2024 $516 · 2025 $1,417
Food & beverage: $1,417
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $489 |
| Alkermes, Inc. | 2 | $188 |
| ABBVIE INC. | 3 | $150 |
| Janssen Pharmaceuticals, Inc | 1 | $133 |
| Supernus Pharmaceuticals, Inc. | 1 | $119 |
| Axsome Therapeutics, Inc. | 1 | $115 |
| E.R. Squibb & Sons, L.L.C. | 1 | $113 |
| Vanda Pharmaceuticals Inc. | 1 | $112 |
Products named: REXULTI, VRAYLAR, SPRAVATO, ARISTADA, Qelbree, Auvelity, COBENFY, FANAPT.
Industry payments across NY — which companies pay providers there.
